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1. Introduction 
Transporters, located in the cell surface plasma membrane and intracellular organelle 
membrane, compose a major class of integral membrane proteins, as distinguished with 
their specialized functions as channels and receptors. They are divided into two groups of 
gene family; one is the solute carrier (SLC) super family and the other is the ATP-binding 
cassette (ABC) gene family (Giacomini & Sugiyama, 2006). The transporters for 
neurotransmitters in the plasma membrane, which belong to the SLC6 gene family, 
terminate synaptic neurotransmission by Na+/Cl--dependent uptake of released 
neurotransmitters into the neuronal and/or glial cells (Iversen, 1971). They are responsible 
for the reuptake not only of neurotransmitters, monoamines (dopamine (DA), noradrenaline 
(NA), and serotonin (5-HT)) and amino acids (-aminobutyric acid (GABA) and glycine), but 
also of neuromodulators and/or osmolytes (proline, taurine, betaine, and creatine). Cloning 
of their cDNA has facilitated the understanding of the primary structure, gene expression, 
and their roles in neuronal functions (Amara & Kuhar, 1993). Cellular and molecular aspects 
of these transporters are needed for the clarification of their physiological and pathological 
relevance, since it seems likely that alterations of their structure, function and expression 
produce their anatomical and functional divergence, resulting in an involvement of a 
number of neurological and psychiatric disorders.  
Elucidating the molecular structure of these transporters should be a first step to clarify their 
functional mechanisms, such as transport processes, regulations and consequent 
phenomena. Particularly, information of the membrane topology is substantially important 
for clarifying their structure-function relationship. Among the Na+/Cl--dependent 
neurotransmitter transporters, this chapter focuses on the monoamine neurotransmitter 
transporters such as those for DA (DAT), NA (NET), and 5-HT (SERT). These monoamine 
transporters are of particular interest, since they are a target of drugs of abuse and/or 
antidepressants, and are involved in various neuronal disorders (Gether et al., 2006). 
Therefore, understanding of the expression and function of these transporters could promise 
clues to clarify their pathophysiological significance and thereby to develop medications for 
treatments of neuronal disorders mentioned above.  
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Cloning of the GABA transporter (GAT) cDNA and subsequently the NET cDNA have led 
to the identification of the gene family, such as SLC6 (Amara & Kuhar, 1993). Hydropathy 
analysis1 of the primary structure of these transporters showed a common model for their 
membrane topology; the twelve hydrophobic regions that consist of -helical 
transmembrane domains (TMDs) interrupted by alternating intra- and extracellular loops, 
one large putatively extracellular loop, and intracellularly localization of N- and C-termini 
(Fig. 1A). Based on this information, initial studies have examined the membrane topology 
of the transporters using various biochemical techniques including, for example, an 
immunological technique with specific antibodies against hydrophilic regions predicted as 
intra- and extracellular loops, or antibodies against known epitope tags incorporated at 
hydrophilic regions of the neurotransmitter transporters in the transiently or stably 
expressing cell lines. Recent success of the X-ray crystallography of the bacterial homologue 
of the Na+/Cl--dependent neurotransmitter transporter LeuT confirmed the proposed model 
and extended the structural understanding (Yamashita et al., 2005) (Fig. 1B). However, it is 
still difficult to understand fully the structure of mammalian plasma membrane 
neurotransmitter transporters. In addition to more studies on X-ray crystallography of 
bacterial homologues, we are needed to address directly to the mammalian transporter 
proteins to determine their membrane topology.  
We have been investigating the expression and function of DAT and NET isoforms 
produced by alternative RNA splicing (Kitayama & Dohi, 2003). Recently, we found novel 
variants of human DAT (hDAT) and NET, skipping the region encoded by exon 6 (Sogawa 
et al., 2010). A hydropathy analysis of the variant designated hDATEX6 revealed 11 
putative TMDs, suggesting a membrane topology different from that of full-length (FL) 
hDAT. To explore the unique structure of this variant, an immunocytochemical analysis 
with confocal microscopy was performed using two specific antibodies, one recognizing the 
second extracellular region (anti-hDAT-EL2 antibody) and the other recognizing the 
intracellular C-terminus (anti-hDAT-Ct antibody) in the tranfected cells treated with 
(permeabilized) or without (non-permeabilized) surfactant Triton. Immunoreactivity to the 
anti-hDAT-Ct antibody was only observed in FL hDAT-expressing cells treated with Triton, 
in contrast to the detection even in the untreated cells expressing hDATEX6, strongly 
suggesting the C-terminus of hDATEX6 to be located extracellulary. This information of 
the membrane topology is substantially important for clarifying the structure-function 
relationship. Since changes in membrane topology could influence the expression and 
function of the transporter at large, our observations provide clue to understand the 
functional modifications and expressional alterations of the DAT/NET splice variants.  
In this chapter, we summarize the recent progress in our understanding of the contribution 
of the immunocytochemical approaches to determining a membrane topology of the plasma 
membrane neurotransmitter transporters. We discuss a usefulness of specific antibodies 
against the epitopes located in the extra- and/or intra-cellular region of plasma membrane 
protein, that led us to identify the unique structure of the DAT/NET splice variants. We also 
discuss the additional molecular biological and protein engineering techniques in 
                                                 
1 An index that progressively evaluates the hydrophilicity and hydrophobicity of a protein along its 
amino acid sequence, thereby predicts higher structure of proteins. For this purpose, a hydropathy scale 
has been composed wherein the hydrophilic and hydrophobic properties of each of the 10-20 amino 
acid side-chains is taken into consideration.  
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comparison of their benefits and problems. In addition, we summarized basic methods 
concerning cell preparations, gene transfection techniques into mammalian cell lines, and 
fixation and permeabilization of cell cultures.  
 
Fig. 1. Schematic presentation of the topological model of the neurotransmitter transporter 
(A) and LeuT (B). (A) Transmembrane helices are shown as cylinders and are numbered 1-
12. Helical features are based on the hydropathy analysis of deduced amino acid sequence 
of the cloned transporter cDNA. The C and N termini are intracellular. (B) Model of LeuT in 
the plasma membrane based on its crystal structure. S: substrate leucine, closed circle: Na+.  
2. General consideration of the neurotransmitter transporter 
2.1 Cloning of cDNAs  
Cloning of their cDNA has facilitated the understanding of the primary structure, gene 
expression, and their roles in neuronal functions. The GABA transporter-1 (GAT-1) cDNA 
was cloned from rat brain as a first one of the gene family by means of protein purification 
(Guastella et al., 1990). Hydropathy analysis of the deduced protein suggested multiple 
TMDs that did not display homology to any previously identified proteins as assessed by 
database search, indicating that GAT-1 appeared to be a member of a previously 
uncharacterized family of transporter.  
Soon after the cloning of GAT-1, human NET cDNA was cloned by direct expression of 
pools of clones from a human SK-N-SH cell cDNA library in COS-1 cells and screening for 
5 4 2
1a 6b
7 9 10 11 12
NH2
COOH
[out]
[in]
1b 6a
S
EL4
COOH
NH2
in
out
1 2 3 4 5 6 7 8 9 10 11 12
A
B
www.intechopen.com
 
Applications of Immunocytochemistry 
 
120 
transfectants expressing NET using radiolabelled noradrenaline (NA) analogue m-
iodobenzylguanidine (Pacholczyk et al., 1991). The predicted protein sequence of NET 
demonstrated significant amino acid identity with GAT-1, identifying a new gene family for 
neurotransmitter transporter proteins.  
This conclusion was confirmed by the subsequent cloning of other neurotransmitter 
transporters, such as DAT and SERT, in which degenerative oligonucleotides based on 
conservative amino acid sequences between GAT-1 and NET were used to amplify cDNA 
fragments from brain mRNA to screen cDNA library and clone them. Hydropathy analysis 
of their primary structures again suggested a membrane topological model for the proteins 
belonging to the Na+/Cl- -dependent transporter family (Fig. 1A). All members of this 
family share the twelve hydrophobic regions that consist of -helical TMDs interrupted by 
alternating intra- and extracellular loops, one large putatively extracellular loop, and 
intracellularly localization of N- and C-termini (Amara & Kuhar, 1993).  
2.2 Functional roles 
The major function of the neurotransmitter transporters located on the cell surface plasma 
membrane is to terminate synaptic neurotransmission by Na+/Cl--dependent uptake of 
released neurotransmitters into the neuronal and/or glial cells (Iversen, 1971). Transport of 
substrate such as neurotransmitter is driven by Na+ gradient as energy source created by 
Na+,K+-ATPase, thereby being usually from extracellular to intracellular side. This 
intracellular accumulation of neurotransmitters acts not only to maintain synaptic clearance 
of the released neurotransmitters but also to regulate the storage and consequently release 
of neurotransmitters in the synaptic vesicles in concert with the vesicular neurotransmitter 
transporters located on the synaptic vesicle membrane. Therefore, they regulate 
spatiotemporal components of the neurotransmission. This has been supported by analysis 
of the neurotransmitter transporter knockout mice. The first evidence came from DAT 
knockout mice that were characterized by a dopamine-deficient but hyperdopaminergic 
state as a result of reduced dopamine clearance and reduced vesicular storage of dopamine 
(Giros et al., 1996; Jones et al., 1998). Loss of a transport function could thus cause severe 
disease or lethality, for instance, in the case of loss-of-function DAT mutants in infantile 
parkinsonism-dystonia in humans (Kurian et al., 2009).  
According to the transport process mentioned above, changes in driving force such as Na+ 
gradient might cause reversal of transport. The discovery of reverse transport has been 
brought about by the study of the pharmacology of sympathomimetic amines including 
amphetamine, a psychostimulant drug abused widely, and now probably all the 
neurotransmitter transporters are considered to possess bidirectional transport (Sitte & 
Freishmuth, 2010). Another feature of the neurotransmitter transporter is channel-like 
activity, showing coupled and uncoupled currents (Gerstbrein & Sitte, 2006). These are 
important issues to consider roles of the neurotransmitter transporter in physiology and 
pathology, however, out of scope in this chapter. For details see those references. 
3. Biochemical approaches to the membrane topology 
A number of approaches have been designed to determine the topological arrangement of 
membrane spanning segments in protein subunits, and allowed to reveal an insight into the 
structure of membrane proteins. Fig. 2 summarizes such strategies, which include:  
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1. Development of site-directed antibodies for use in immunocytochemistry (Fig. 2A)  
2. Detection of glycosylation sites inserted into hydrophilic domains (Fig. 2B)  
3. Determination of the orientation of a reporter domain linked to a series of C-terminal 
truncation using a protease protection assays (Fig. 2C)  
4. Chemical modification of specific amino acid residues using membrane-permeant and -
impermeant reagents (Fig. 2D)  
5. Immunocytochemical detection of the epitope-tag inserted into hydrophilic domains or 
fused to truncated (intact) C-terminal (Fig. 2E)  
Each approach has its own benefit but also limitation, because many of the approaches 
require modification of the protein being studied, which often results in changes of the 
functional properties due to perturbation of the structure of the protein (Green et al., 2001). 
The neurotransmitter transporter protein is not tolerant of the alterations in primary 
sequence at conserved domain, such as the insertion of reporter epitope or the mutagenesis 
of several amino acid residues. Therefore, it appears to allow minor modification, such as 
substitution of single amino acid residue with cysteine, for example. Since substitution with 
cysteine appears to be very tolerated, it is useful for evaluating the membrane topology to 
determine the intra- and extracellular orientation of substituted cysteine residues using 
membrane-permeant and -impermeant sulfhydryl-reactive agents. A residue which is 
water-accessible from the cytoplasmic side but not from the extracellular side of the 
membrane should not react at an appreciate rate with extracellularly applied MTSET or 
MTSES (impermeant reagent), but might react with MTSEA (permeant reagent). In this way, 
topology can be assessed under conditions in which protein function and structure remain 
unaltered (Javitch, 1998).  
All members of the Na+/Cl—dependent neurotransmitter transporter gene family share the 
twelve hydrophobic regions that might consist of α-helical transmembrane domains 
(TMDs) interrupted by alternating intra- and extracellular loops, one large putatively 
extracellular loop, and intracellularly localization of N- and C-termini. Based on this 
information, initial studies examined the membrane topology of the transporters by various 
biochemical techniques. For example, study with immunological technique using specific 
antibodies against hydrophilic regions predicted as intra- and extracellular loops or 
antibodies against known epitope tags incorporated at hydrophilic regions of the 
neurotransmitter transporters transiently or stably expressed in the cell lines, strongly 
confirm the topological model, as described below.  
3.1 Site-directed antibodies  
Mabjeesh and Kanner have reported the first evidence for the membrane topology of GAT 
using antibodies raised against synthetic peptides corresponding to several regions of the 
rat brain GAT-1 (Mabjeesh & Kanner, 1992). According to the model based on the 
hydropathy analysis, these 4 antibodies against amino and carboxy termini and predicted 
3rd and 4th intracellular loops recognized the intact transporter on Western blots. 
Interestingly, GAT protein digested partially at amino and carboxy termini by protease 
revealed transport activity when reconstituted in liposomes, suggesting that these regions 
are not essential for transport function (Mabjeesh and Kanner, 1992). These studies did not 
address directly to explore the membrane topology of the transporter, however, provided 
useful information for the subsequent topological studies (Fig. 2A).  
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Fig. 2. Schematic presentations of the strategies for identifying membrane topology. (A) Site-
directed antibodies were developed for use in immunocytochemistry. (B) Detection of 
glycosylation sites (N-X-S/T) inserted into hydrophilic domains was performed after 
deletion of endogenous sites (X). (C) The orientation of a reporter domain linked to a series 
of C-terminal truncation was determined using a protease protection assays. (D) Chemical 
modification of specific amino acid residues (Cys) was performed using membrane-
permeant and -inpermeant reagents. (E) The epitope-tag was inserted into hydrophilic 
domains, or fused to truncated (intact) C-terminal, and the immunocytochemical detection 
was performed.  
Antibodies have been raised against synthetic peptides derived from the predicted primary 
sequence of the human NET at several hydrophilic regions (Melikian et al., 1994). 
Immunocytochemical study with one antibody raised against a putative intracellular loop 
(N430, hNET 430-444) demonstrated that it detected hNET expression in a stably transfected 
cell line (LLC-NET) only in the presence of detergent, suggesting the predicted membrane 
topology. Bruss et al. investigated the membrane topology of human NET using polyclonal 
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antibodies raised against peptides corresponding to hydrophilic sequences; N- and C-
terminal peptides of the hNET, as well as against peptides from the putative extracellular 
loops between TMDs 3 and 4 and TMDs 7 and 8 (Bruss et al., 1995). They confirmed the 
topological model mentioned above.  
Site-directed antibodies to the human DAT have been raised against its hydrophilic regions 
(Vaghan et al., 1993). Using these antibodies, the authors identified ligand binding domains 
of DAT with the photoaffinity compounds and limited proteolysis (Vaughan, 1995; Vaughan 
& Kuhar, 1996). The data experimentally verified an aspect of theoretical model of the 
transporter. Hersch et al. have raised monoclonal antibodies against the predicted N-
terminus and second extracellular loop of DAT, and determined the subcellular location of 
DAT by immunoperoxidase and immunogold electron microscopy (Hersch et al., 1997). 
Immunogold labeling the intracellular and extracellular epitopes was found in the 
complementary positions that would be predicted based on molecular models of DAT in 
which the N-terminus is intracellular and the large third extramembranous loop is 
extracellular. 
3.2 N-glycosylation scanning mutagenesis  
Kanner’s group further examined the membrane topology of GAT-1 by N-glycosylation 
scanning mutagenesis (Bennett & Kanner, 1997). Insertion of glycosylation sites into 
hydrophilic regions predicted as linker loop was tolerated well, although the approach is 
not straightforward in accordance with earlier studies using this approach on transporters 
(Fig. 2B). Overall, the results supported the theoretical 12 TMD model. However, they 
indicated that the loop connecting putative TMD 2 and 3, which was predicted to be located 
intracellularly, could be glycosylated in vivo. In addition, studies with permeant and 
impermeant methane sulfonate reagent suggested that Cys74, located in the hydrophilic 
loop connecting TMD 1 and 2, was intracellular rather than extracellular. Based on these 
results, they proposed a model in which the topology deviated from the theoretical one in 
the amino-terminal third of the transporter; the highly conserved TMD1 did not form a 
conventional TMD.  
Olivares et al. proposed a similar topological model for GLYT1 using same approach 
(Olivares et al., 1997). The data supported a rearrangement of the first third of the protein, 
and consistent with Kanner’s proposal that hydrophobic domain 1 seems not to span the 
membrane, and the loop connecting hydrophobic domain 2 and 3, formally believed to be 
intracellular, appears to be extracellularly located.  
However, the subsequent studies on the membrane topology of SERT have argued against 
this alternative topology (Chen et al., 1998). They examined the SERT membrane topology 
by measuring the reactivity of selected lysine and cysteine with extracellular reagents. The 
cysteine-specific biotinylation reagent N-biotinylaminoethylmethanethiosulfonate (MTSEA-
biotin) labeled wild-type SERT but not a mutant in which Cys-109, predicted to lie in the 
first external loop, was replaced with alanine. All of the mutants tested were active and 
therefore likely to be folded correctly. Therefore, these results support the original 
transmembrane topology. Recent findings of the X-ray crystallography of the bacterial 
homologue of the neurotransmitter transporter confirmed the original model (Yamashita et 
al., 2005), and this is discussed in the later section.  
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3.3 Protease protection assay  
Clark performed different approach to clarify the membrane topology of GAT-1 (Clark, 
1997). She generated a series of C-terminal truncations to which a prolactin epitope was 
fused. Following expression of transporter-prolactin chimeras in Xenopus oocytes, protease 
protection assays were performed to determine the transmembrane orientation (Fig. 2C). 
The data indicated that N- and C-termini were cytosolic and hydrophobic domains spanned 
the membrane in a manner consistent with the predicted hydropathy model.  
Furthermore, the author showed that residues in the loops connecting hydrophobic domains 
3 and 4 (predicted EL2), and those 7 and 8 (EL4) are accessible to protease in the cytoplasm, 
suggesting the presence of pore loop structures which extend into the membrane from the 
extracellular face (Clark, 1997). However, as mentioned above, the neurotransmitter 
transporter protein is not tolerant of the alterations in primary sequence at conserved 
domain, the insertion of reporter epitope such as prolactin might perturb the structure of the 
protein like the case for N-gycosylation scanning mutagenesis. Again, the findings of LeuT 
structure did not support pore loop structure (Yamashita et al., 2005).  
3.4 Chemical modification  
Of particular importance for investigating the membrane topology is to maintain functional 
properties intact under experimental conditions. As already mentioned, application of the 
substituted cysteine accessibility method (SCAM) can indirectly probe structure and 
conformational dynamics in the neurotransmitter transporters (Javitch, 1998) (Fig. 2D). The 
human DAT has 13 cysteines. Ferrer and Javitch have sought to identify those cysteine 
residuesthe modification of which affects cocaine analogue binding and to determine the 
topology of these reactive cysteines by mutating each of the cysteines, one at a time and in 
various combinations (Ferrer & Javitch, 1998). They demonstrated that Cys-90 and Cys-306 
appear to be extracellular, and Cys-135 and Cys-342 appear to be intracellular, each of these 
residues is predicted to be in extramembranous loops, supporting the hypothetical 
membrane topology of the neurotransmitter transporter. More importantly, the binding of 
cocaine increases the rate of reaction of MTSEA and MTS ethyltrimethylammonium with the 
extracellular Cys-90 and therefore acts by inducing a conformational change. Usefulness of 
SCAM to investigate structure-function relationship of the neurotransmitter transporters led 
to the subsequent success in this field.  
3.5 Epitope-tagging  
Insertion of epitope-tag into hydrophilic region often perturbs structure of the 
neurotransmitter transporter proteins. However, a hemagglutinin epitope (HA) tag has been 
successfully introduced into the second extracellular loop (EL2) of DAT (Sorkina et al., 2006) 
(Fig. 2E). They confirmed that all their attempts to introduce epitopes into other parts of EL2 
or into EL6 produced mutants that did not efficiently exit the endoplasmic reticulum. Ciliax 
et al. demonstrated an antibody to the C-terminal part of EL2 that recognizes the human 
DAT (Ciliax et al., 1995). However, Sorkina et al. could not find conditions under which the 
antibody binds DAT in living cells, and they suggested that this part of the loop is not 
assessable under physiological conditions (Sorkina et al., 2006).  
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4. X-ray crystallography of LeuT  
The structure of Aquifex aeolicus leucine transporter (LeuTAa), a bacterial homologue of 
mammalian Na+/Cl—dependent neurotransmitter transporter, has been solved recently 
(Yamashita et al., 2005). Although the overall sequence identity between LeuT and its 
mammalian counterparts is low (20-25%), several regions within transmembrane segments 
1, 3, 6, and 8 displays ~50% conservation. Examination of the structure of the crystallized 
LeuT protein revealed such structure as a “occluded form ” with substrate leucine and Na+. 
There is an unexpected structural repeat in the first ten TMDs that relates TMD1-5 with 
TMD6-10 around a pseudo-twofold axis of symmetry located in the membrane plane (Fig. 
1B). The pseudo-repeats are oriented antiparallel to one another with the two central TMDs, 
1 and 6, which are unwound near the substrate and Na+ binding sites, located halfway 
across the lipid bilayer. This unwinding structure is important for understanding the 
structure-function relationship, because it exposes helix dipoles to maintain carbonyl 
oxygen and amide nitrogen for substrate binding and Na+ coordination.  
Subsequent studies added further structural models by indicating an occluded form with 
tricyclic antidepressant (TCA) (Singh et al., 2007; Zhou et al., 2007) and an outward-facing 
form with competitive inhibitor tryptophan (Singh et al., 2008). The structure of TCA-LeuT 
complex reveals a TCA binding pocket, called “extracellular vestibule”, composed of 7 
amino acid residues, which are located approximately 11 Angstrom above the substrate 
leucine binding site, and accommodated with EL4. Comparison of the original LeuT 
structure and TCA-LeuT complex reveals a hypothetical extracellular gate in a closed 
conformation formed by the conserved R30 in TMD 1 and D404 in TMD 10 that is formed 
when two coordinating water molecules are displaced. A second salt bridge observed in the 
original LeuT structure formed intracellularly between R5 in N-terminus and D369 in TMD 
8, which is proposed to play a role in intracellular gating (Yamashita et al., 2005). Inward-
facing conformation of LeuT has not been identified yet, that helps to understand fully the 
alternative access model of the transporter.  
There are limits to the evaluation of mammalian neurotransmitter transporters by what a 
distantly related bacterial homologue can provide. EL2 as well as N- and C-termini are 
considerably shorter in LeuT, and none of the intracellular loops harbor consensus 
sequences for phosphorylation. Furthermore, it seems unlikely to be evaluated using 
electrophysiological techniques required to characterize channel activities of the 
neurotransmitter transporters, as mentioned in the section 2.2 (Gerstbrein & Sitte, 2006).   
5. Immunocytochemical approaches to the DAT splice variants  
We have been investigating the expression and function of DAT and NET isoforms 
produced by alternative RNA splicing (Kitayama & Dohi, 2003). Recently we found novel 
splice variants of human DAT and NET designated hDATEX6 and hNETEX6, skipping 
the region encoded by exon 6 (Sogawa et al., 2010). Hydropathy analysis of the variants 
revealed putative 11 TMDs, and an immunocytochemical analysis with confocal microscopy 
suggested a membrane topology different from that of full-length (FL) hDAT, such as that 
the C-terminus could be located extracellulary. In this section, we summarize these findings, 
and discuss further possibility of future works.  
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5.1 C-terminal orientation of the splice variants 
C-terminal of the neurotransmitter transporters is no doubt intracellular. A hydropathy 
analysis of hDATEX6 revealed 11 putative transmembrane domains (TMDs), suggesting a 
membrane topology different from that of the original full-length (FL) hDAT. If TMDs are 
inserted behind the truncation, the C-terminus could be located extracellulary. To explore 
this possibility, we performed an immunocytochemical analysis with confocal microscopy 
using two specific antibodies, one recognizing the second extracellular region (anti-hDAT-
EL2 antibody) and the other recognizing the intracellular C-terminus (anti-hDAT-Ct 
antibody). Among the MDCK cells stably expressing FL hDAT, immunoreactivity to the 
anti-hDAT-Ct antibody was only observed in those cells treated with Triton (Fig. 3A). 
Among the MDCK cells expressing hDATEX6, however, immunoreactivity to the anti-
hDAT-Ct antibody was detected even in the untreated cells (Fig. 3B). Control experiments 
using the anti-hDAT-EL2 antibody showed immunoreactivity in the Triton-treated and 
untreated cells expressing both FL hDAT (Fig. 3A) and hDATEX6 (Fig. 3B). These results 
strongly suggest the C-terminus of hDATΔEX6 to be located extracellulary.  
Deletion of the region encoded by exon 6 in the hDATEX6 variant is believed to affect the 
orientation of those TMD regions that follow. The present findings, suggesting the C-
terminal region to be located extracellularly, did not indicate the exact membrane topology 
of each TMD including the 7-12th TMDs. A previous study suggested an alternative 
membrane topology consisting of TMD in the EL2 region corresponding to the involvement 
of N-terminal regions TM1 and TM2, as mentioned in the previous section. A predicted 
membrane topology of hDATEX6 simply reflected the sequence of hydrophobic regions 
considered as TMDs. Therefore, further study is needed to determine the precise membrane 
topology of the hDATEX6 variant.  
Since C-terminal region is well known to participate an important role in the expression and 
function of neurotransmitter transporters, a putative extracellular location of C-terminus in 
the hDATEX6 variant suggests a differential feature of its roles. Previous studies with DAT 
mutants have suggested several possibilities of the C-terminus-dependent mechanisms 
underlying DAT regulation; (1) an elimination of phosphorylation in the C-terminal region 
by PKC (Holton et al., 2005), (2) a loss of interaction with proteins such as PICK1 in the PDZ 
domain at the C-terminal end (Torres et al., 2001), and (3) an unknown mechanism 
independent of interaction with the PDZ protein at the C-terminus (Bjerggaard et al., 2004). 
Studies on C-terminal splice variants of hNET also documented a critical contribution of the 
hNET C-terminus to transporter trafficking, stability, and function (Sogawa et al., 2007). 
These explanations seem unlikely in the case of hDATEX6, since the present findings 
suggested the C-terminus of hDATΔEX6 to be located extracellulary. At present, it is 
unknown how trafficking of hDATEX6 to the plasma membrane is regulated, and further 
study is needed to clarify this.  
5.2 Oligomerization  
We also found that hDATEX6 had a dominant negative effect on FL hDAT, possibly 
through the formation of heterooligomeric complexes, as suggested by the results of the 
immunoprecipitation assays (Sogawa et al., 2010). A cell surface biotinylation assay with an   
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Fig. 3. Cell surface expression of the DAT splice variants determined immunocytochemically 
with two antibodies against different epitopes in stably transfected MDCK cells. Cells stably 
expressing FL hDAT (A) and hDATΔEX6 (B) were treated with (a, b) or without (c, d) 
Triton, and examined for immunocytochemistry with two different antibodies. From 
Sogawa et al., 2010 (doi: 10.1371/jounal.pone.0011945.g007).  
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immunoblot analysis using the anti-hDAT-EL2 antibody demonstrated a reduction in the 
expression of the 80-85kDa hDAT at the cell surface, on co-expression with hDATEX6. An 
immunoblot analysis using the anti-HA antibody to the HA-tagged FL hDAT demonstrated 
that co-expression of hDATEX6 decreased the cell surface expression of the 80-85kDa 
mature hDAT, in consistent with the decreased Vmax of [3H]DA uptake. Interaction among 
the isoforms was further examined by conducting immunopreciptation assays using tagged 
forms of hDAT, such as HA-hDAT and N-terminally His-tagged hDATEX6 (His-
hDATEX6). The proteins precipitated with the anti-His antibody were subjected to an 
immunoblot analysis using the anti-hDAT-EL2 antibody and anti-HA antibody. Isolation of 
His-hDATEX6 with the anti-His antibody allowed the detection of HA-hDAT using the 
anti-HA antibody when the two proteins were expressed simultaneously, indicating that FL 
hDAT and hDATEX6 form heterooligomeric complexes. It seems unlikely to be a 
nonspecific aggregation with other membrane proteins including neurotransmitter 
transporters, since an immunoprecipitation with anti-His antibody did not detect HA-
tagged mouse glutamate transporter GLT-1 in COS-7 cells co-transfected with His- 
hDATEX6, in association with the lack of an effect on [3H]glutamate uptake through 
mGLT-1 (Sogawa et al., 2010).  
There is a growing body of evidence that oligomerization is necessary for the cell surface 
expression of neurotransmitter transporters including DAT (Torres et al., 2003). The 
structure of LeuT suggested dimerization through interaction at the 9th and 12th TMDs 
(Yamashita et al., 2005). However, it seems unlikely that FL hDAT and hDATEX6 interact 
in these regions, since according to the predicted membrane topology of hDATEX6, the C-
terminal region is located extracellulary, preventing direct interaction. Torres et al. found 
that the C-terminal of DAT was not essential for oligomerization, and that a small fragment 
comprising the first two TMDs inhibited the wild-type transporter function but not when 
the leucine repeat motif present in the 2nd TMD was mutated (Torres et al., 2003). However, 
it is unclear whether FL hDAT and hDATEX6 associate in the same way, since 
immunoprecipitation assays do not reveal modes of interaction and no information is 
available about the membrane topology of hDATEX6 except the C-terminus. Therefore, 
further study is needed to determine the mechanism by which hDATEX6 forms a 
heterooligomeric complex with FL hDAT.  
It might be probable that hDATEX6 interacts with FL hDAT at the plasma membrane to 
produce a dominant negative effect on the activity of FL hDAT, since a part of the 
hDATEX6 protein was observed in the plasma membrane (Sogawa et al., 2010). However, 
there is evidence that the functional unit of the transporter is a monomer, though isoforms 
or different transporters such as NET and SERT consist of heterodimers (Kocabas et al., 
2003). Further study is needed to clarify this possibility.  
6. Protocol  
The followings are methods related to our report described in the previous section 5. We 
summarize the points necessary to perform the immunocytochemical approach to the 
membrane topology of DAT as a typical model of the neurotransmitter transporters.  
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6.1 Cell preparation and transfection  
6.1.1 Cell culture  
COS-7 cells and MDCK cells (RIKEN Cell Bank, Tsukuba, Japan) were maintained in 
Dulbecco’s modified Eagle’s medium (DMEM) supplemented with 10% fetal bovine serum, 
100 units/ml penicillin-G, 100 g/ml streptomycin and 2.5 g/ml fungizone at 37 C under 
5% CO2/95% air.  
6.1.2 Vector construction  
Cloning of full-length cDNAs of human DAT variants, FL hDAT and hDATEX6, were 
performed by RT-PCR at three discrete and overlapping regions in first strand cDNA pool 
synthesized from white blood cells total RNA. The products were isolated from agarose gel, 
digested with KpnI, BanHI, NgoMIV or XhoI, and subcloned into pcDNA3 at KpnI/XhoI 
digestion site. The isolated each clone was analyzed by restriction enzyme digestion and 
nucleotide sequencing2.  
Human NET variant cDNAs (FL hNET and hNETEX6) were isolated from human cDNA 
library made from SK-N-SH cells by PCR, and cloned into pcDNA3 at EcoRI/XhoI 
digestion site (Kitayama et al., 2001). mGLT-1 cDNA (AK134609) in plasmid vector pFLC1 
was obtained from RIKEN Mouse FANTOM FLS through KK DNAFORM, and a BamHI 
fragment containing ORF was subcloned into pcDNA3, as described (Sogawa et al.,  
2010).  
6.1.3 Transfection 
COS-7 cells at subconfluence were harvested and transfected with pcDNA3 alone or with 
pcDNA3 containing hDAT, hNET, or mGLT cDNA and/or variant cDNA by 
electroporation or using FuGENE6 according to the manufacturer’s directions (Roche 
Diagnostics, Mannheim, Germany). Electroporated cells were diluted in culture medium, 
plated in 24-well tissue culture plates and cultured for 2-3 days. For immunological 
analyses, COS-7 cells at subconfluence in 60-mm diameter Petri dishes (for Western blotting) 
or Falcon BIOCOAT® Cellware rat tail collagene, type I 4-well culture slides (Becton 
Dickinson Labware, Bedford, MA) (for immunocytochemistry) were transfected with 
cDNAs using FuGENE6.  
6.1.4 Cloning of cell lines 
To generate stably transfected MDCK cells, we transfected pcDNA3 harboring FL hDAT or 
hDATEX6 using FuGENE6 into MDCK cells and selected in 600 g/ml Geneticin (G418). 
Individual cells were used to generate clonal lines. Multiple lines tested positive for 
immunocytochemistry using rabbit anti-hDAT polyclonal antibody. MDCK cells stably 
expressing FL hDAT and hDATEX6 were passaged in DMEM culture media containing 
10% fetal bovine serum, 100 U/ml penicillin, 100 g/ml streptomycin, 2.5 g/ml fungizone, 
and 600 g/ml G418.  
                                                 
2 Request for these clones and related materials should be addressed to Dr. Shigeo Kitayama, 
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6.2 Immunocytochemistry and confocal microscopy 
6.2.1 Fixation 
For immunological analyses, MDCK cells were diluted in culture medium, plated in Falcon 
BIOCOAT® Cellware rat tail collagene, type I 4-well culture slides and cultured for 2 days. 
Cells were initially rinsed twice with Ca2+- and Mg2+-containing PBS, and then fixed in 4% 
paraformaldehyde (PFA) for 5 min at room temperature. After three washes with PBS, cells 
were treated with (permeabilized) or without (non-permeabilized) 0.25% Triton X-100 for 5 
min at room temperature. If methanol or ethanol fixative was used, every cell was 
permeabilized. We choose 4% PFA fixation, because we need distinguish the permeabilized 
cells from non-permeabilized cells.  
6.2.2 Immunostaining 
After permeabilization, the slides were washed with PBS and incubated in blocking solution 
(2% goat serum) for 30 min at room temperature. Cells were incubated with rabbit anti-
hDAT polyclonal antibody (anti-hDAT-Ct antibody against NH2-
CEKDRELVDRGEVRQFTLRHWL, Chemicon, AB1766, 1:500; anti-hDAT-EL2 antibody 
against NH2-CHLHQSHGIDDLGPPRWQ, Chemicon, AB5802, 1:250)) for overnight at 4 °C, 
followed by incubation with FITC-conjugated anti-rabbit secondary antibody (Sigma-
Aldrich Corporation, St. Louis, MO).  Cells were then washed three times with PBS, and the 
filter with cells was excised from its support and mounted on a slide glass with Perma 
Fluor® aqueous mounting medium (Thermo Shandon, Pittsburgh, PA, USA).  
6.2.3 Confocal microscopy 
After a final wash for immunostaining of MDCK cells grown on Falcon BIOCOAT® culture 
slides (Becton Dickinson Labware, Bedford, MA) performed as above, the cells were covered 
by coverslip with mounting medium. Immunofluorescent images were generated using a 
Zeiss laser scanning confocal microscope (LSM510).  
7. Conclusion  
The plasma membrane neurotransmitter transporters, such as members of the SLC6 gene 
family, act to terminate neurotransmission by Na+/Cl- -dependent uptake of released 
neurotransmitters, thereby maintaining their synaptic clearance, and fine-tuning synaptic 
transmission. Common structure of these transporters predicted by hydropathy analysis 
showed twelve hydrophobic transmembrane domains with intracellular amino- and 
carboxy-termini. Biochemical and immunocytochemical studies supported this structure one 
by one. Recent findings of the X-ray crystallography of a bacterial homologue, LeuT, 
confirmed such structure as a “occluded form ” with substrate leucine and Na+, and the 
subsequent studies added further occluded form with antidepressant and out-ward facing 
form with competitive inhibitor tryptophan. Based on these observations, combinatory 
approaches might provide further evidence supporting the membrane topology of the 
neurotransmitter transporter. These strategies will develop the future studies on the 
structure-function relationship of the neurotransmitter transporters that promises clues to 
develop new targets for therapeutics of transporter-associated disorders.  
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